Dagyagnao, Agnes B.

HRN: 17-95-25  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/06/2025
02/12/2025
IV
4.5gm LD Then 2.25gm Q6H
Q6
Cap Mr
Rejected 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines